Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.24 and traded as high as $3.68. Hypera shares last traded at $3.68, with a volume of 178 shares traded.
Hypera Stock Performance
The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41. The firm has a 50-day simple moving average of $3.24 and a 200-day simple moving average of $3.76.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
- Five stocks we like better than Hypera
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 3 Stocks to Consider Buying in October
- 3 Must-Own Stocks to Build Wealth This Decade
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
